Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
07/28/1998 | US5786186 DNA encoding enzymes of the glycolytic pathway for use in alcohol producing yeast |
07/28/1998 | US5786184 Lactic bacteria producing exopolysaccharides |
07/28/1998 | US5786183 Contacting sample comprising target nucleic acid with a combination of at least three oligonucleotide primers, contacting with proteins having specific enzyme activities, amplifying |
07/28/1998 | US5786181 Process for producing high purity 6, 12-dideoxyerythromycin A by fermentation |
07/28/1998 | US5786180 Antibody specific for peptide derived from amyloid precursor protein |
07/28/1998 | US5786179 Heterologous protein comprising avian alpha-subunit inhibin protein and methods of producing same |
07/28/1998 | US5786177 Diagnosis of viral infections |
07/28/1998 | US5786176 Recombinant chinese hamster ovary or baby hamster kidney cell line capable of expressing recombinant antigen or fragment thereof in form recognizable by antibodies raised against human antigen |
07/28/1998 | US5786174 Thermophile gene transfer |
07/28/1998 | US5786173 MCH4 and MCH5, apoptotic protease, nucleic acids encoding and methods of use |
07/28/1998 | US5786171 Aortic preferentially expressed gene and uses thereof |
07/28/1998 | US5786169 CDI1 polypeptides |
07/28/1998 | US5786168 Method for recombinant production of antigen non-specific glycosylation inhibiting factor (GIF) |
07/28/1998 | US5786166 Methods for determining effects of a compound on the activity of bacterial periplasmic oxidoreductase enzymes |
07/28/1998 | US5786163 BNP antibody and immunoassay using it |
07/28/1998 | US5786162 Genetic engineering |
07/28/1998 | US5786160 Monoclonal antibodies, glycoproteins and immunology |
07/28/1998 | US5786159 Method of producing antibodies to a restricted population of T lymphocytes antibodies produced therefrom and methods of use thereof |
07/28/1998 | US5786158 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
07/28/1998 | US5786157 DNA encoding human 5-HT1D receptors and uses thereof |
07/28/1998 | US5786155 Methods for identifying a compound that binds to a human 5-HT 1E receptor |
07/28/1998 | US5786154 Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis |
07/28/1998 | US5786150 F0 ATP synthase subunit |
07/28/1998 | US5786149 Materials and methods for the detection of mycobacterium tuberculosis |
07/28/1998 | US5786148 Genetic engineering and expression vectors for antisense molecules |
07/28/1998 | US5786141 Electrogenerated chemiluminescence labels for analysis and/or referencing |
07/28/1998 | US5786140 DNA's encoding sucrose isomerase and palatinase |
07/28/1998 | US5786138 Ribonucleic acid sequences, oligonucleotide and binders |
07/28/1998 | US5785992 Liposomes and cationic compounds |
07/28/1998 | US5785986 Water channel |
07/28/1998 | US5785971 Pertussis toxin and use in vaccines |
07/28/1998 | US5785968 Useful for the diagnosis, treatment and prevention of feline virus infections |
07/28/1998 | US5785967 Antibodies immunoreactive with leukemia inhibitory factor receptors |
07/28/1998 | US5785966 Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients |
07/28/1998 | US5785735 Phytoremediation of metals |
07/28/1998 | US5784992 Apparatus for injecting avian embryo muscle tissue in ovo |
07/28/1998 | CA2221686A1 Asp2 |
07/28/1998 | CA2220851A1 Cdna clone he8ch90 that encodes a novel 7-transmembrane receptor |
07/28/1998 | CA2148684C Bacillus thuringiensis isolates active against lepidopteran pests |
07/28/1998 | CA2012632C Process for the expression of a recombinant gene |
07/28/1998 | CA2010582C A tryptamine producing tryptophan decarboxylase gene of plant origin |
07/24/1998 | CA2220856A1 Cloning of a novel g-protein coupled 7tm receptor |
07/23/1998 | WO1998032017A2 Modulators of insulin receptor activity |
07/23/1998 | WO1998031857A1 Method and device for making composite sheets |
07/23/1998 | WO1998031840A1 Methods of isolating biological target materials using silica magnetic particles |
07/23/1998 | WO1998031838A1 Method for analyzing quantitative expression of genes |
07/23/1998 | WO1998031837A1 Evolution of whole cells and organisms by recursive sequence recombination |
07/23/1998 | WO1998031836A1 Methods and compositions for detection or quantification of nucleic acid species |
07/23/1998 | WO1998031834A1 Sets of labeled energy transfer fluorescent primers and their use in multi component analysis |
07/23/1998 | WO1998031833A1 Nucleic acid sequencing with solid phase capturable terminators |
07/23/1998 | WO1998031832A1 Method and kit for diagnosis of an increased risk of cardiovascular diseases |
07/23/1998 | WO1998031831A1 Nucleic acid sequencing |
07/23/1998 | WO1998031830A1 Mass label linked hybridisation probes |
07/23/1998 | WO1998031828A1 Constitutively active g protein coupled receptor of hhv 8 and method |
07/23/1998 | WO1998031826A1 Practical in vitro sialylation of recombinant glycoproteins |
07/23/1998 | WO1998031823A1 Rna binding protein and binding site useful for expression of recombinant molecules |
07/23/1998 | WO1998031822A1 Pathogen-induced plant promoters |
07/23/1998 | WO1998031821A2 Dna sequences, vectors, and fusion polypeptides for secretion of polypeptides in filamentous fungi |
07/23/1998 | WO1998031819A1 Expression in yeast of antigenically active, recombinant hybrid glutamic acid decarboxylase |
07/23/1998 | WO1998031818A2 Tace-like and matrilysin-like polypeptides |
07/23/1998 | WO1998031817A2 Human lysosomal sialidase and therapeutic uses thereof |
07/23/1998 | WO1998031816A1 Dna molecules and protein displaying improved triazine compound degrading ability |
07/23/1998 | WO1998031815A2 Subunits of nadh dehydrogenase |
07/23/1998 | WO1998031814A1 Epitopes of the protein pre-m/m of the dengue virus, synthetic peptides |
07/23/1998 | WO1998031813A1 Inhibitors of antigen presentation by mhc class i molecules |
07/23/1998 | WO1998031812A1 Strawberry promoters and genes |
07/23/1998 | WO1998031811A1 Member of the hematopoietin receptor superfamily |
07/23/1998 | WO1998031810A2 Mammalian chemokines; receptors; reagents; uses |
07/23/1998 | WO1998031809A1 Human cc chemokine slc |
07/23/1998 | WO1998031808A1 Biological material for treating a mammal by antibody gene transfer and pharmaceutical composition containing same |
07/23/1998 | WO1998031807A1 Novel means for the diagnosis, prevention and treatment of contamination or infections by viruses with mucous tropism |
07/23/1998 | WO1998031806A2 Fc RECEPTORS AND POLYPEPTIDES |
07/23/1998 | WO1998031805A2 Human zinc binding proteins |
07/23/1998 | WO1998031804A1 NEURONAL bHLH-PAS DOMAIN PROTEINS |
07/23/1998 | WO1998031803A1 Therapies involving mutated heat shock transcription factor |
07/23/1998 | WO1998031802A2 Secreted proteins and polynucleotides encoding them |
07/23/1998 | WO1998031801A1 I-flice, a novel inhibitor of tumor necrosis factor receptor-1 and cd-95 induced apoptosis |
07/23/1998 | WO1998031800A2 Human proteins |
07/23/1998 | WO1998031799A2 Polynucleotides and polypeptides encoding receptors |
07/23/1998 | WO1998031798A1 Human extracellular matrix-1 |
07/23/1998 | WO1998031797A1 Zppar6, human tailless nuclear hormone receptor (tlx receptor) |
07/23/1998 | WO1998031796A1 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons |
07/23/1998 | WO1998031795A2 Novel human metallothionein |
07/23/1998 | WO1998031794A1 Vegf-binding polypeptide |
07/23/1998 | WO1998031793A2 Immunomodulating properties, amino acid and nucleotide sequence of colostrum derived growth factor |
07/23/1998 | WO1998031792A1 Hematopoietic signaling factor |
07/23/1998 | WO1998031789A1 Nucleic acid encoding m. tuberculosis algu protein |
07/23/1998 | WO1998031786A2 Novel microorganisms |
07/23/1998 | WO1998031709A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use |
07/23/1998 | WO1998031707A2 Transgenic animals with disrupted npy y1 receptor genes |
07/23/1998 | WO1998031700A1 Selection of proteins using rna-protein fusions |
07/23/1998 | WO1998031398A1 Microparticles for delivery of nucleic acid |
07/23/1998 | WO1998031397A1 Treatment of diabetes with synthetic beta cells |
07/23/1998 | WO1998031395A1 Adenoviral-vector-mediated gene transfer into medullary motor neurons |
07/23/1998 | WO1998031388A1 Abundant extracellular products and methods for their production and use |
07/23/1998 | WO1998031376A1 Osteocalcin promoter-based toxic gene therapy |
07/23/1998 | WO1998031324A2 Genetic alterations associated with cancer |
07/23/1998 | WO1998026050A3 Glutathionylspermidine synthetase |
07/23/1998 | WO1998021337A3 C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE) |
07/23/1998 | WO1998020906A3 Treatment of diabetes with transcription factor gene |